Reconstituted: Refrigerate at 28 C (35.646.4 F) and use within about 4 weeks
Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) Tri-Compound Oral Research Formulation x 60 Tablets Oral solid-form research compound formulated for controlled analytical and investigational applications
Related products Related products Related products
In highly concentrated samples, the biocompatible enhanced viscosity formulation comprises at least about 25%, at least about 35%, at least about 45%, at least about 55%, at least about 65%, at least about 75%, at least about 85%, at least about 90%, at least about 95%, or more by weight of the active agent
This damage occurs due to heat, chemicals, electric shock, or thermal factors
Where is BPC-157 manufactured